Table 2.
Factors associated with cfDNA levels.
| Yes | No | P Value | ||
|---|---|---|---|---|
| Gender (male) | 383 (173–1435) | 346 (159–628) | 0.121 | |
| Hypertension | 383 (158–665) | 405 (173–999) | 0.999 | |
| Diabetes | 185 (127–688) | 383 (179–913) | 0.512 | |
| Dyslipidaemia | 383 (167–913) | 346 (164–657) | 0.978 | |
| Atrial fibrillation | 384 (172–672) | 309 (151–801) | 0.972 | |
| Tobacco use | 597 (237–1447) | 346 (158–673) | 0.373 | |
| Coronary disease | 321 (147–808) | 383 (172–650) | 0.961 | |
| Previous stroke | 639 (102–2045) | 383 (166–657) | 0.632 | |
| Previous disability | 617 (135–1099) | 383.5 (167–688) | 0.943 | |
| Proximal occlusion | 408 (206–665) | 309 (115–801) | 0.470 | |
| OCSP | TACI | 252 (143–578) | 0.041 | |
| PACI | 657 (180–999) | |||
| POCI | 1099 (432–1135) | |||
| LACI | – | |||
| TOAST | Atherothrombotic | 179 (100–371) | 0.433 | |
| Cardioembolic | 433 (173–808) | |||
| Lacunar | – | |||
| Undetermined | 297 (172–575) | |||
| Uncommon | – | |||
| 48-h improvement | 227 (135–688) | 457 (309–927) | 0.123 | |
| Correlation coefficient | p Value | |||
| Age | R = −0.075 | 0.589 | ||
| Baseline NIHSS | R = −0.096 | 0.492 | ||
| SBP | R = 0.072 | 0.612 | ||
| DBP | R = 0.095 | 0.503 | ||
| Glycaemia | R = −0.167 | 0.242 | ||
| Time to tPA | R = −0.065 | 0.646 | ||
NIHSS: National Institutes of Health Stroke Scale; SBP: systolic blood pressure; DBP: diastolic blood pressure; OCSP: Oxfordshire Stroke Project Classification; TACI: total anterior circulation infarct; PACI: partial anterior circulation infarct; POCI: posterior arterial circulation infarct; LACI: lacunar infarct; TOAST: Trial of Org 10172 in Acute Stroke Treatment classification; tPA: tissue plasminogen activator.
*p < 0.05.